KFDA to gear up campaigns of pharmaceuticals-related regulations

Published: 2002-10-08 06:57:00

Updated: 2002-10-08 06:57:00

The Korea Food and Drug Administration (KFDA) is contemplating a series of briefing sessions related to enactment/revision of Rules concerning license (notice) of Drug, Etc. on September 30 and expanded notice of drugs implemented by the regional KFDA since August 1, in a bid to ensure better app...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK